BSX logo

Boston Scientific (BSX) Net income

annual net income:

$1.85B+$261.00M(+16.38%)
December 1, 2024

Summary

  • As of today (April 16, 2025), BSX annual net profit is $1.85 billion, with the most recent change of +$261.00 million (+16.38%) on December 1, 2024.
  • During the last 3 years, BSX annual net income has risen by +$813.00 million (+78.10%).
  • BSX annual net income is now -60.55% below its all-time high of $4.70 billion, reached on December 31, 2019.

Performance

BSX Net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBSXincome statement metrics

quarterly net income:

$566.00M+$98.00M(+20.94%)
December 1, 2024

Summary

  • As of today (April 16, 2025), BSX quarterly net profit is $566.00 million, with the most recent change of +$98.00 million (+20.94%) on December 1, 2024.
  • Over the past year, BSX quarterly net income has increased by +$98.00 million (+20.94%).
  • BSX quarterly net income is now -85.84% below its all-time high of $4.00 billion, reached on December 31, 2019.

Performance

BSX quarterly net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBSXincome statement metrics

TTM net income:

$1.85B+$61.00M(+3.41%)
December 1, 2024

Summary

  • As of today (April 16, 2025), BSX TTM net profit is $1.85 billion, with the most recent change of +$61.00 million (+3.41%) on December 1, 2024.
  • Over the past year, BSX TTM net income has increased by +$61.00 million (+3.41%).
  • BSX TTM net income is now -60.64% below its all-time high of $4.70 billion, reached on December 31, 2019.

Performance

BSX TTM net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBSXincome statement metrics

Net income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

BSX Net income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+16.4%+20.9%+3.4%
3 y3 years+78.1%+109.6%+102.8%
5 y5 years-60.5%+109.6%+102.8%

BSX Net income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+165.6%at high+414.6%at high+183.3%
5 y5-year-60.5%+2361.0%at high+465.2%-56.9%+2383.9%
alltimeall time-60.5%+145.6%-85.8%+113.3%-60.6%+140.8%

Boston Scientific Net income History

DateAnnualQuarterlyTTM
Dec 2024
$1.85B(+16.4%)
$566.00M(+20.9%)
$1.85B(+3.4%)
Sep 2024
-
$468.00M(+44.4%)
$1.79B(-2.0%)
Jun 2024
-
$324.00M(-34.1%)
$1.82B(+3.0%)
Mar 2024
-
$492.00M(-2.6%)
$1.77B(+11.2%)
Dec 2023
$1.59B(+128.2%)
$505.00M(+0.2%)
$1.59B(+29.7%)
Sep 2023
-
$504.00M(+86.7%)
$1.23B(+34.6%)
Jun 2023
-
$270.00M(-14.0%)
$912.00M(+1.1%)
Mar 2023
-
$314.00M(+124.3%)
$902.00M(+29.2%)
Dec 2022
$698.00M(-32.9%)
$140.00M(-25.5%)
$698.00M(+6.9%)
Sep 2022
-
$188.00M(-27.7%)
$653.00M(-26.1%)
Jun 2022
-
$260.00M(+136.4%)
$884.00M(+9.1%)
Mar 2022
-
$110.00M(+15.8%)
$810.00M(-22.2%)
Dec 2021
$1.04B(-1369.5%)
$95.00M(-77.3%)
$1.04B(-9.9%)
Sep 2021
-
$419.00M(+125.3%)
$1.16B(+98.6%)
Jun 2021
-
$186.00M(-45.5%)
$582.00M(+133.7%)
Mar 2021
-
$341.00M(+62.4%)
$249.00M(-407.4%)
Dec 2020
-$82.00M(-101.7%)
$210.00M(-235.5%)
-$81.00M(-102.2%)
Sep 2020
-
-$155.00M(+5.4%)
$3.71B(-7.0%)
Jun 2020
-
-$147.00M(-1436.4%)
$3.99B(-7.0%)
Mar 2020
-
$11.00M(-99.7%)
$4.29B(-8.8%)
Dec 2019
$4.70B(+181.3%)
$4.00B(+3071.4%)
$4.70B(+331.2%)
Sep 2019
-
$126.00M(-18.2%)
$1.09B(-21.9%)
Jun 2019
-
$154.00M(-63.7%)
$1.40B(-22.3%)
Mar 2019
-
$424.00M(+9.8%)
$1.80B(+7.5%)
Dec 2018
$1.67B(+1506.7%)
$386.00M(-10.6%)
$1.67B(+149.4%)
Sep 2018
-
$432.00M(-22.2%)
$670.00M(+28.6%)
Jun 2018
-
$555.00M(+86.2%)
$521.00M(+365.2%)
Mar 2018
-
$298.00M(-148.5%)
$112.00M(+7.7%)
Dec 2017
$104.00M(-70.0%)
-$615.00M(-317.3%)
$104.00M(-87.7%)
Sep 2017
-
$283.00M(+93.8%)
$843.00M(+7.0%)
Jun 2017
-
$146.00M(-49.7%)
$788.00M(+81.1%)
Mar 2017
-
$290.00M(+133.9%)
$435.00M(+25.4%)
Dec 2016
$347.00M(-245.2%)
$124.00M(-45.6%)
$347.00M(+328.4%)
Sep 2016
-
$228.00M(-210.1%)
$81.00M(-123.5%)
Jun 2016
-
-$207.00M(-202.5%)
-$345.00M(+858.3%)
Mar 2016
-
$202.00M(-242.3%)
-$36.00M(-84.9%)
Dec 2015
-$239.00M(+100.8%)
-$142.00M(-28.3%)
-$239.00M(-39.6%)
Sep 2015
-
-$198.00M(-294.1%)
-$396.00M(+155.5%)
Jun 2015
-
$102.00M(<-9900.0%)
-$155.00M(-38.7%)
Mar 2015
-
-$1.00M(-99.7%)
-$253.00M(+112.6%)
Dec 2014
-$119.00M(-1.7%)
-$299.00M(-795.3%)
-$119.00M(-141.3%)
Sep 2014
-
$43.00M(+975.0%)
$288.00M(+20.0%)
Jun 2014
-
$4.00M(-97.0%)
$240.00M(-34.4%)
Mar 2014
-
$133.00M(+23.1%)
$366.00M(-402.5%)
Dec 2013
-$121.00M(-97.0%)
$108.00M(-2260.0%)
-$121.00M(-28.0%)
Sep 2013
-
-$5.00M(-103.8%)
-$168.00M(-79.7%)
Jun 2013
-
$130.00M(-136.7%)
-$827.00M(-81.8%)
Mar 2013
-
-$354.00M(-680.3%)
-$4.54B(+11.5%)
Dec 2012
-$4.07B(-1022.4%)
$61.00M(-109.2%)
-$4.07B(+1.1%)
Sep 2012
-
-$664.00M(-81.4%)
-$4.02B(+25.1%)
Jun 2012
-
-$3.58B(-3266.4%)
-$3.22B(-733.1%)
Mar 2012
-
$113.00M(+5.6%)
$508.00M(+15.2%)
Dec 2011
$441.00M(-141.4%)
$107.00M(-24.6%)
$441.00M(-22.6%)
Sep 2011
-
$142.00M(-2.7%)
$570.00M(-7.8%)
Jun 2011
-
$146.00M(+217.4%)
$618.00M(+8.4%)
Mar 2011
-
$46.00M(-80.5%)
$570.00M(-153.5%)
Dec 2010
-$1.06B(+3.9%)
$236.00M(+24.2%)
-$1.06B(-55.2%)
Sep 2010
-
$190.00M(+93.9%)
-$2.38B(-10.7%)
Jun 2010
-
$98.00M(-106.2%)
-$2.66B(+2.3%)
Mar 2010
-
-$1.59B(+47.7%)
-$2.60B(+153.8%)
Dec 2009
-$1.02B(-49.7%)
-$1.08B(+1044.7%)
-$1.02B(-56.3%)
Sep 2009
-
-$94.00M(-159.5%)
-$2.34B(+1.4%)
Jun 2009
-
$158.00M(-1315.4%)
-$2.31B(-2.5%)
Mar 2009
-
-$13.00M(-99.5%)
-$2.37B(+16.5%)
Dec 2008
-$2.04B(+311.3%)
-$2.39B(+3761.3%)
-$2.04B(+1936.0%)
Sep 2008
-
-$62.00M(-163.3%)
-$100.00M(-67.7%)
Jun 2008
-
$98.00M(-69.6%)
-$310.00M(+5.8%)
Mar 2008
-
$322.00M(-170.3%)
-$293.00M(-40.8%)
DateAnnualQuarterlyTTM
Dec 2007
-$495.00M(-86.2%)
-$458.00M(+68.4%)
-$495.00M(-306.3%)
Sep 2007
-
-$272.00M(-336.5%)
$240.00M(-59.2%)
Jun 2007
-
$115.00M(-4.2%)
$588.00M(-115.5%)
Mar 2007
-
$120.00M(-56.7%)
-$3.79B(+5.9%)
Dec 2006
-$3.58B(-669.6%)
$277.00M(+264.5%)
-$3.58B(+1.6%)
Sep 2006
-
$76.00M(-101.8%)
-$3.52B(-8.9%)
Jun 2006
-
-$4.26B(-1383.7%)
-$3.87B(-742.0%)
Mar 2006
-
$332.00M(-0.6%)
$602.00M(-4.1%)
Dec 2005
$628.00M(-40.9%)
$334.00M(-224.2%)
$628.00M(+6.3%)
Sep 2005
-
-$269.00M(-231.2%)
$591.00M(-47.1%)
Jun 2005
-
$205.00M(-42.7%)
$1.12B(-8.8%)
Mar 2005
-
$358.00M(+20.5%)
$1.23B(+15.4%)
Dec 2004
$1.06B(+125.0%)
$297.00M(+15.1%)
$1.06B(+17.7%)
Sep 2004
-
$258.00M(-17.6%)
$902.00M(+17.4%)
Jun 2004
-
$313.00M(+61.3%)
$768.00M(+35.0%)
Mar 2004
-
$194.00M(+41.6%)
$569.00M(+20.6%)
Dec 2003
$472.00M(+26.5%)
$137.00M(+10.5%)
$472.00M(+7.3%)
Sep 2003
-
$124.00M(+8.8%)
$440.00M(-7.8%)
Jun 2003
-
$114.00M(+17.5%)
$477.00M(+22.9%)
Mar 2003
-
$97.00M(-7.6%)
$388.00M(+4.0%)
Dec 2002
$373.00M(-790.7%)
$105.00M(-34.8%)
$373.00M(+12.0%)
Sep 2002
-
$161.00M(+544.0%)
$333.00M(+44.8%)
Jun 2002
-
$25.00M(-69.5%)
$230.00M(+597.0%)
Mar 2002
-
$82.00M(+26.2%)
$33.00M(-161.1%)
Dec 2001
-$54.00M(-114.5%)
$65.00M(+12.1%)
-$54.00M(-8.5%)
Sep 2001
-
$58.00M(-133.7%)
-$59.00M(+84.4%)
Jun 2001
-
-$172.00M(+3340.0%)
-$32.00M(-112.2%)
Mar 2001
-
-$5.00M(-108.3%)
$262.00M(-29.8%)
Dec 2000
$373.00M(+0.5%)
$60.00M(-29.4%)
$373.00M(-11.2%)
Sep 2000
-
$85.00M(-30.3%)
$420.00M(+7.7%)
Jun 2000
-
$122.00M(+15.1%)
$390.00M(+3.4%)
Mar 2000
-
$106.00M(-0.9%)
$377.00M(+1.6%)
Dec 1999
$371.00M(-240.5%)
$107.00M(+94.5%)
$371.00M(+10.7%)
Sep 1999
-
$55.00M(-49.5%)
$335.00M(-284.1%)
Jun 1999
-
$109.00M(+9.0%)
-$182.00M(-18.8%)
Mar 1999
-
$100.00M(+40.8%)
-$224.00M(-15.2%)
Dec 1998
-$264.00M(-340.0%)
$71.00M(-115.4%)
-$264.00M(-27.1%)
Sep 1998
-
-$462.00M(-789.6%)
-$361.90M(-292.0%)
Jun 1998
-
$67.00M(+11.7%)
$188.50M(+99.3%)
Mar 1998
-
$60.00M(-323.0%)
$94.60M(-14.0%)
Dec 1997
$110.00M(-34.2%)
-$26.90M(-130.4%)
$110.00M(-49.4%)
Sep 1997
-
$88.40M(-428.6%)
$217.50M(+8.6%)
Jun 1997
-
-$26.90M(-135.7%)
$200.30M(-16.6%)
Mar 1997
-
$75.40M(-6.5%)
$240.30M(+46.6%)
Dec 1996
$167.10M(-1008.2%)
$80.60M(+13.2%)
$163.90M(+303.7%)
Sep 1996
-
$71.20M(+443.5%)
$40.60M(+147.6%)
Jun 1996
-
$13.10M(-1410.0%)
$16.40M(-66.7%)
Mar 1996
-
-$1.00M(-97.7%)
$49.20M(-367.4%)
Dec 1995
-$18.40M(-123.0%)
-$42.70M(-190.9%)
-$18.40M(-138.6%)
Sep 1995
-
$47.00M(+2.4%)
$47.70M(+132.7%)
Jun 1995
-
$45.90M(-166.9%)
$20.50M(-410.6%)
Mar 1995
-
-$68.60M(-393.2%)
-$6.60M(-108.3%)
Dec 1994
$80.00M(+14.8%)
$23.40M(+18.2%)
$80.00M(+4.0%)
Sep 1994
-
$19.80M(+5.3%)
$76.90M(+3.4%)
Jun 1994
-
$18.80M(+4.4%)
$74.40M(+2.8%)
Mar 1994
-
$18.00M(-11.3%)
$72.40M(+3.9%)
Dec 1993
$69.70M(+23.1%)
$20.30M(+17.3%)
$69.70M(+7.2%)
Sep 1993
-
$17.30M(+3.0%)
$65.00M(+3.3%)
Jun 1993
-
$16.80M(+9.8%)
$62.90M(+5.9%)
Mar 1993
-
$15.30M(-1.9%)
$59.40M(+4.9%)
Dec 1992
$56.60M(+35.4%)
$15.60M(+2.6%)
$56.60M(+9.7%)
Sep 1992
-
$15.20M(+14.3%)
$51.60M(+9.1%)
Jun 1992
-
$13.30M(+6.4%)
$47.30M(+5.6%)
Mar 1992
-
$12.50M(+17.9%)
$44.80M(+7.2%)
Dec 1991
$41.80M
$10.60M(-2.8%)
$41.80M(+34.0%)
Sep 1991
-
$10.90M(+0.9%)
$31.20M(+53.7%)
Jun 1991
-
$10.80M(+13.7%)
$20.30M(+113.7%)
Mar 1991
-
$9.50M
$9.50M

FAQ

  • What is Boston Scientific annual net profit?
  • What is the all time high annual net income for Boston Scientific?
  • What is Boston Scientific annual net income year-on-year change?
  • What is Boston Scientific quarterly net profit?
  • What is the all time high quarterly net income for Boston Scientific?
  • What is Boston Scientific quarterly net income year-on-year change?
  • What is Boston Scientific TTM net profit?
  • What is the all time high TTM net income for Boston Scientific?
  • What is Boston Scientific TTM net income year-on-year change?

What is Boston Scientific annual net profit?

The current annual net income of BSX is $1.85B

What is the all time high annual net income for Boston Scientific?

Boston Scientific all-time high annual net profit is $4.70B

What is Boston Scientific annual net income year-on-year change?

Over the past year, BSX annual net profit has changed by +$261.00M (+16.38%)

What is Boston Scientific quarterly net profit?

The current quarterly net income of BSX is $566.00M

What is the all time high quarterly net income for Boston Scientific?

Boston Scientific all-time high quarterly net profit is $4.00B

What is Boston Scientific quarterly net income year-on-year change?

Over the past year, BSX quarterly net profit has changed by +$98.00M (+20.94%)

What is Boston Scientific TTM net profit?

The current TTM net income of BSX is $1.85B

What is the all time high TTM net income for Boston Scientific?

Boston Scientific all-time high TTM net profit is $4.70B

What is Boston Scientific TTM net income year-on-year change?

Over the past year, BSX TTM net profit has changed by +$61.00M (+3.41%)
On this page